Chelsea Hardin, MD, FACS
“I believe that every patient deserves compassionate, quality health care delivered in a timely fashion.”
Dr. Chelsea Hardin is a board-certified general surgeon with a special interest in the surgical treatment of breast cancer. She has had specialty training in placement of accelerated partial breast irradiation (APBI) catheters, skin and nipple-sparing mastectomies, as well as hidden-scar oncoplastic techniques for the surgical management of breast cancer.
Prior to practicing in Portland, Dr. Hardin helped to open and run a breast center in San Diego. She chose to become a surgeon because it gives her the opportunity to use both her mind and her hands to repair a problem for someone who is suffering. She likes being able to offer a solution that helps get a person back to their regular life.
Outside of the office, Dr. Hardin enjoys running, cooking, and being active with her two young children.
- Residency, General Surgery, Oregon Health & Science University, Portland, OR, 2006
- Internship, General Surgery, Oregon Health & Science University, Portland, OR, 2001
- MD, University of Utah School of Medicine, Salt Lake City, UT, 2000
- BS, Human Biology, University of Utah, Salt Lake Cit, UT, 1995
- Affiliate Assistant Professor, OHSU Division of GI and General Surgery
- St. Vincent Medical Executive Committee, member
- Breast Cancer Leadership Team, Co-Chair Grossmont Hospital (08-14)
- Grossmont Hospital Cancer Committee (07 –14)
- OR Steering Committee, Grossmont Hospital (07 –14)
- Surgery Supervisory Committee, Grossmont Hospital (09 –14)
- Tumor Board, Appointed member Grossmont Hospital (06 – 14)
- Outcomes Committee , Surgeon member Grossmont Hospital (07 – 10)
- Alpha Omega Alpha (AOA) Medical Honor Society, 2006
- Senior Member, OHSU Resident Advisory Committee, 2005-2006
- William S. Fletcher Traveling Fellowship Award, 2004-2005
- Best OHSU Resident Research Paper Award, 2004-2005
- Resident of the Year Award, St. Vincent’s Hospital, 2004-2005
- Martin Howard Award for Best Surgical Research Paper, 2003-2004
- Hardin C, Toth-Fejel S, Pommier R et al. A new hormonal therapy for estrogen receptor negative breast cancer. World J Surg. 2007; 31(5): 1041-6.
- Hardin C, Toth-Fejel S, Pommier R et al. The relationships between clinician delay of diagnosis of breast cancer and tumor size, nodal status and stage. Am J Surg, 2006 192: 506-508.
- Hardin C, Toth-Fejel S, Pommier R et al. Understanding the biological mechanisms responsible for breast cancer progression during tamoxifen or fulvestrant treatment. Am J Surg. 2004 Oct; 188(4):426-8.
- Invited speaker, community outreach seminar ("Current Treatment of Breast Cancer")
- Resident Teaching Faculty, St. Vincent’s Hospital
- The American College of Surgeons
- The American Society of Breast Surgeons
- Oregon Medical Society
- San Diego County Medical Society